Notice: This company has been marked as potentially delisted and may not be actively trading. Cleveland BioLabs (CBLI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CBLI vs. SCPS, VAXX, AMPE, EVLO, CMRA, STAB, CALA, CLVR, MTEM, and EFTRShould you be buying Cleveland BioLabs stock or one of its competitors? The main competitors of Cleveland BioLabs include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Ampio Pharmaceuticals (AMPE), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Statera Biopharma (STAB), Calithera Biosciences (CALA), Clever Leaves (CLVR), Molecular Templates (MTEM), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "medical" sector. Cleveland BioLabs vs. Scopus BioPharma Vaxxinity Ampio Pharmaceuticals Evelo Biosciences Comera Life Sciences Statera Biopharma Calithera Biosciences Clever Leaves Molecular Templates eFFECTOR Therapeutics Scopus BioPharma (NASDAQ:SCPS) and Cleveland BioLabs (NASDAQ:CBLI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, community ranking, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Does the MarketBeat Community favor SCPS or CBLI? Cleveland BioLabs received 274 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 55.87% of users gave Cleveland BioLabs an outperform vote. CompanyUnderperformOutperformScopus BioPharmaOutperform Votes2100.00% Underperform VotesNo VotesCleveland BioLabsOutperform Votes27655.87% Underperform Votes21844.13% Which has stronger earnings and valuation, SCPS or CBLI? Cleveland BioLabs has higher revenue and earnings than Scopus BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScopus BioPharmaN/AN/A-$11.61MN/AN/ACleveland BioLabs$260K0.00-$2.40MN/AN/A Do institutionals and insiders believe in SCPS or CBLI? 5.1% of Cleveland BioLabs shares are held by institutional investors. 5.1% of Scopus BioPharma shares are held by company insiders. Comparatively, 1.0% of Cleveland BioLabs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to SCPS or CBLI? In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Cleveland BioLabs'average media sentiment score. Company Overall Sentiment Scopus BioPharma Neutral Cleveland BioLabs Neutral Is SCPS or CBLI more profitable? Scopus BioPharma's return on equity of 0.00% beat Cleveland BioLabs' return on equity.Company Net Margins Return on Equity Return on Assets Scopus BioPharmaN/A N/A N/A Cleveland BioLabs N/A -32.84%-31.29% Which has more risk & volatility, SCPS or CBLI? Scopus BioPharma has a beta of -0.19, suggesting that its stock price is 119% less volatile than the S&P 500. Comparatively, Cleveland BioLabs has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. SummaryCleveland BioLabs beats Scopus BioPharma on 5 of the 9 factors compared between the two stocks. Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLI vs. The Competition Export to ExcelMetricCleveland BioLabsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$7.08B$5.83B$9.13BDividend YieldN/A2.75%4.75%3.85%P/E RatioN/A6.1426.8119.22Price / SalesN/A250.79428.3269.65Price / CashN/A65.6738.0134.83Price / BookN/A6.707.644.62Net Income-$2.40M$138.98M$3.19B$246.06M Cleveland BioLabs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLICleveland BioLabsN/AN/AN/AN/A$5,000.00$260,000.000.004Analyst ForecastSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009VAXXVaxxinityN/A$0.00-98.0%N/A-99.3%$13,000.00N/A0.0090Upcoming EarningsAMPEAmpio PharmaceuticalsN/A$0.01flatN/A-99.9%$11,000.00N/A0.0020Analyst ForecastNews CoverageEVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9,000.00N/A0.00120Upcoming EarningsOptions VolumeNews CoverageCMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$630,000.000.002High Trading VolumeSTABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020CALACalithera BiosciencesN/A$0.00flatN/A-97.6%$3,000.00N/A0.0060Analyst ForecastNews CoverageCLVRClever LeavesN/A$0.00+900.0%N/A-100.0%$2,000.00$17.42M0.00560Gap UpHigh Trading VolumeMTEMMolecular TemplatesN/A$0.00flatN/A-100.0%$2,000.00$57.31M0.00260EFTReFFECTOR Therapeutics1.0676 of 5 stars$0.00flat$24.00+11,999,900.0%-100.0%$1,000.00$3.55M0.0010 Related Companies and Tools Related Companies Scopus BioPharma Alternatives Vaxxinity Alternatives Ampio Pharmaceuticals Alternatives Evelo Biosciences Alternatives Comera Life Sciences Alternatives Statera Biopharma Alternatives Calithera Biosciences Alternatives Clever Leaves Alternatives Molecular Templates Alternatives eFFECTOR Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBLI) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cleveland BioLabs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBLI Stock Alerts